AI assistant
Sending…
ANI PHARMACEUTICALS INC — Director's Dealing 2011
Aug 5, 2011
31676_dirs_2011-08-05_c84373fe-a87f-42fc-b624-abf15fa01b8d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOSANTE PHARMACEUTICALS INC (BPAX)
CIK: 0001023024
Period of Report: 2011-08-05
Reporting Person: MANGANO ROSS J (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-08-05 | Common Stock | P | 80000 | $2.21 | Acquired | 165756 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1929661 | Indirect |
| Common Stock | 30000 | Indirect |
| Common Stock | 48333 | Indirect |
| Common Stock | 33333 | Indirect |
| Common Stock | 33333 | Indirect |
| Common Stock | 100000 | Indirect |
Footnotes
F1: Shares are held by Oliver & Co., of which Mr. Mangano is a trustee.
F2: Shares are held indirectly by Mr. Mangano in various trusts of which Mr. Mangano is the trustee.
F3: Shares are indirectly held by Mr. Mangano as an investment advisor on behalf of an individual.
More from ANI PHARMACEUTICALS INC
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Report Publication Announcement
2026
May 13
Interim / Quarterly Report
2026
May 8
Report Publication Announcement
2026
May 8
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 4
Investor Presentation
2026
Mar 3